Home LiteratureArticle Details
PMID: 3039164 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Monoclonal antibody-aided characterization of cellular p220 in uninfected and poliovirus-infected HeLa cells: subcellular distribution and identification of conformers.

Journal of virology ·Vol. 61 ·No. 9 ·1987-09-00 ·Pages 2702-10

Etchison D, Etchison JR

Abstract

A monoclonal antibody directed against the Mr-220,000 subunit (p220) of the mRNA cap-binding complex has been prepared and used to analyze the sucrose gradient sedimentation and subcellular location of p220 and its poliovirus-induced cleavage products. The antibody reacted with p220 on immunoblots of cell lysates from uninfected cells, but only with several smaller polypeptides, the p220 cleavage products, in cell lysates from poliovirus-infected cells. The sedimentation of p220 antigens from uninfected or infected cells was analyzed by immunoblot and by enzyme-linked immunosorbent assay (ELISA) of sucrose gradient fractions. The results indicate that antibody reactivity was partially influenced by antigen conformation. Major forms of intact p220 and cleaved p220 were identified by immunoblot, and these had similar sedimentation properties. ELISA analysis of the same gradient fractions detected only uncleaved p220; p220 cleavage products were not recognized. Furthermore, the antibody recognized two forms of native uncleaved p220, one of which appeared to bind antibody with greater affinity. This result suggested the existence of conformational variants of p220. The differential reactivity of the antibody for cleaved versus uncleaved p220 served as a useful control during indirect immunofluorescence analysis to determine the subcellular distribution of p220 antigens. The distribution of p220 in uninfected cells was mainly cytoplasmic, but some nuclear antigens were also apparent. After poliovirus infection only the nuclear pattern remained. Disappearance of the cytoplasmic pattern confirmed the inability of the antibody to react with native p220 cleavage products. The cytoplasmic pattern also disappeared after human rhinovirus 14 infection, but not after mengovirus infection, results which correlated with the ability of human rhinovirus 14 and the inability of mengovirus to induce the cleavage of p220. The results demonstrate that p220 is not likely to be associated with the cytoskeleton and hint at the possibility of a partially nuclear location.

MeSH Terms
Amino Acid Sequence Animals Antibodies, Monoclonal/immunology Antigens/analysis Carrier Proteins/analysis Centrifugation, Density Gradient Cytoskeleton/immunology Enzyme-Linked Immunosorbent Assay Fluorescent Antibody Technique HeLa Cells Humans Mengovirus/metabolism Mice Peptide Initiation Factors/analysis,immunology,metabolism Poliovirus/metabolism Protein Biosynthesis Protein Conformation RNA Cap-Binding Proteins
Chemicals
Antibodies, Monoclonal Antigens Carrier Proteins Peptide Initiation Factors RNA Cap-Binding Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Etchison D
Etchison J R
References (38)
38 references, click to expand
  1. On the structure of rhinovirus 1A.
    Virology. 1971 May;44(2):259-70 PMID: 4327717
  2. Shutoff of host translation by encephalomyocarditis virus infection does not involve cleavage of the eucaryotic initiation factor 4F polypeptide that accompanies poliovirus infection.
    J Virol. 1985 May;54(2):643-5 PMID: 2985829
  3. A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5'-terminal cap in mRNA.
    Proc Natl Acad Sci U S A. 1978 Oct;75(10):4843-7 PMID: 217002
  4. The cytoskeletal framework and poliovirus metabolism.
    Cell. 1979 Feb;16(2):289 301 PMID: 222454
  5. Purification of a factor that restores translation of vesicular stomatitis virus mRNA in extracts from poliovirus-infected HeLa cells.
    Proc Natl Acad Sci U S A. 1980 Feb;77(2):770-4 PMID: 6244584
  6. Viral polypeptides associated with the RNA replication complex in poliovirus-infected cells.
    Virology. 1980 Nov;107(1):135-42 PMID: 6255676
  7. Messenger RNA is translated when associated with the cytoskeletal framework in normal and VSV-infected HeLa cells.
    Cell. 1981 Jan;23(1):113-20 PMID: 6260369
  8. Specific disruption of vimentin filament organization in monkey kidney CV-1 cells by diphtheria toxin, exotoxin A, and cycloheximide.
    Proc Natl Acad Sci U S A. 1980 Dec;77(12):7267-71 PMID: 6784120
  9. Presence of the cap-binding protein in initiation factor preparations from poliovirus-infected HeLa cells.
    J Virol. 1981 May;38(2):438-45 PMID: 6264121
  10. Effect of vanadate on intracellular distribution and function of 10-nm filaments.
    Proc Natl Acad Sci U S A. 1981 Apr;78(4):2363-7 PMID: 6941295
  11. Two forms of purified m7G-cap binding protein with different effects on capped mRNA translation in extracts of uninfected and poliovirus-infected HeLa cells.
    J Biol Chem. 1981 Aug 10;256(15):7691-4 PMID: 6267020
  12. Molecular recognition and the future of monoclonal antibodies.
    Nature. 1982 Mar 18;296(5854):200-2 PMID: 7063025
  13. Characterization of eukaryotic initiation factor 4A, a protein involved in ATP-dependent binding of globin mRNA.
    J Biol Chem. 1982 May 10;257(9):5246-52 PMID: 7068683
  14. Association of cap-binding protein with eucaryotic initiation factor 3 in initiation factor preparations from uninfected and poliovirus-infected HeLa cells.
    J Virol. 1982 Apr;42(1):200-7 PMID: 6283140
  15. Association of a Mr 50,000 cap-binding protein with the cytoskeleton in baby hamster kidney cells.
    Proc Natl Acad Sci U S A. 1982 May;79(9):2927-31 PMID: 7045875
  16. Immunochemical characterization of mammalian protein synthesis initiation factors.
    Biochemistry. 1982 Aug 31;21(18):4206-12 PMID: 6751385
  17. Probing the function of the eukaryotic 5'-cap structure using monoclonal antibodies to cap-binding proteins.
    Curr Top Cell Regul. 1982;21:65-88 PMID: 6754270
  18. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex.
    J Biol Chem. 1982 Dec 25;257(24):14806-10 PMID: 6294080
  19. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells.
    Cell. 1982 Nov;31(1):11-24 PMID: 6186379
  20. Protein synthesis eukaryotic initiation factors 4A and 4B are not altered by poliovirus infection of HeLa cells.
    J Biol Chem. 1983 Jun 10;258(11):7236-9 PMID: 6304085
  21. Involvement of eukaryotic initiation factor 4A in the cap recognition process.
    J Biol Chem. 1983 Sep 25;258(18):11398-403 PMID: 6604056
  22. CAP binding proteins associated with the nucleus.
    Nucleic Acids Res. 1983 Sep 10;11(17):5821-35 PMID: 6889136
  23. On the nature of crossreactions observed with antibodies directed to defined epitopes.
    Proc Natl Acad Sci U S A. 1982 Oct;79(19):5939-43 PMID: 6193510
  24. Translational initiation factor and ribosome association with the cytoskeletal framework fraction from HeLa cells.
    Cell. 1984 May;37(1):85-93 PMID: 6722878
  25. Demonstration in vitro that eucaryotic initiation factor 3 is active but that a cap-binding protein complex is inactive in poliovirus-infected HeLa cells.
    J Virol. 1984 Sep;51(3):832-7 PMID: 6088805
  26. Characterization of monoclonal antibody specific for human alpha interferon.
    Hybridoma. 1982;1(3):313-22 PMID: 6208132
  27. Poliovirus mutant that does not selectively inhibit host cell protein synthesis.
    Mol Cell Biol. 1985 Nov;5(11):2913-23 PMID: 3018486
  28. ATP-dependent unwinding of messenger RNA structure by eukaryotic initiation factors.
    J Biol Chem. 1985 Jun 25;260(12):7651-8 PMID: 3838990
  29. Structural analysis of the messenger RNA cap-binding protein. Presence of phosphate, sulfhydryl, and disulfide groups.
    J Biol Chem. 1986 Jan 5;261(1):71-5 PMID: 3941087
  30. Two-dimensional gel analyses of the 24-kDa cap binding protein from poliovirus-infected and uninfected HeLa cells.
    Virology. 1986 Jul 30;152(2):497-501 PMID: 3014728
  31. Presence of proteolytically processed keratins in the culture medium of MCF-7 cells.
    Cancer Res. 1986 Dec;46(12 Pt 1):6353-9 PMID: 2430694
  32. Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220.
    J Virol. 1987 Sep;61(9):2711-8 PMID: 3039165
  33. Probing the function of the eucaryotic 5' cap structure by using a monoclonal antibody directed against cap-binding proteins.
    Cell. 1981 Dec;27(3 Pt 2):563-72 PMID: 6101207
  34. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.
    Biochem J. 1963 Oct;89:114-23 PMID: 14097352
  35. Effect of viral infection on host protein synthesis and mRNA association with the cytoplasmic cytoskeletal structure.
    J Cell Biol. 1985 Apr;100(4):1209-18 PMID: 2984214
  36. Isolation and structural characterization of cap-binding proteins from poliovirus-infected HeLa cells.
    J Virol. 1985 May;54(2):515-24 PMID: 2985814
  37. Human rhinovirus 14 infection of HeLa cells results in the proteolytic cleavage of the p220 cap-binding complex subunit and inactivates globin mRNA translation in vitro.
    J Virol. 1985 May;54(2):634-8 PMID: 2985827
  38. A cytoskeletal structure with associated polyribosomes obtained from HeLa cells.
    Cell. 1977 Jan;10(1):67-78 PMID: 837445
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1987-09-00
Pages
2702-10
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC255776
Subset
IM
Grants
NIAID NIH HHS · AI-17267 · United States
NIAID NIH HHS · AI-24356 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com